Recent Development of ATP-competitive Small Molecule Phosphatidylinostitol-3-Kinase Inhibitors as Anticancer Agents

Oncotarget - United States
doi 10.18632/oncotarget.12742
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

From Oncogene to Drug: Development of Small Molecule Tyrosine Kinase Inhibitors as Anti-Tumor and Anti-Angiogenic Agents

Oncogene
Cancer ResearchGeneticsMolecular Biology
2000English

Discovery of Small Molecule Integrin Avb3 Antagonists as Novel Anticancer Agents

English

3d-Qsar Analysis of Pyrimidine Derivatives as AXL Kinase Inhibitors as Anticancer Agents

Journal of Applied Pharmaceutical Science
MedicineToxicologyPharmaceuticsPharmacology
2018English

Small Molecule FLT3 Tyrosine Kinase Inhibitors

2012English

Structural Analysis of PIM1 Kinase Complexes With ATP-competitive Inhibitors

Scientific Reports
Multidisciplinary
2017English

Correction: Small-Molecule Inhibitors of Acetyltransferase P300 Identified by High-Throughput Screening Are Potent Anticancer Agents

Molecular Cancer Therapeutics
Cancer ResearchOncology
2013English

Small Molecule Tyrosine Kinase Inhibitors in Pancreatic Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Discovery of Inhibitors of Aurora/PLK Targets as Anticancer Agents

English

Recent Patents on Bacterial Proteins as Potential Anticancer Agents

2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy